Trial
NCT00646659
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
—
Condition
Head and Neck Cancer
Intervention
cetuximab
Why stopped
Recruitment was suspended prematurely for safety concerns and closed after IDMC review
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-09